Advertisement

Rabu, 24 April 2019

BNY has quietly started working with a marijuana ETF — and it's about to be the first major bank to help the world's largest funds invest in the booming industry

Institutional investors have previously avoided investing in cannabis because no federally chartered banks would hold the stock. BNY has changed that.
April 24, 2019   |   View Online »
 
BNY has quietly started working with a marijuana ETF — and it's about to be the first major bank to help the world's largest funds invest in the booming industry

BNY has quietly started working with a marijuana ETF — and it's about to be the first major bank to help the world's largest funds invest in the booming industry

Jeremy Berke,Meghan Morris | Institutional investors have previously avoided investing in cannabis because no federally chartered banks would hold the stock. BNY has changed that.

Read More »
The head of Credit Suisse's blockchain efforts said culture is the biggest thing holding back Wall Street from using the tech

The head of Credit Suisse's blockchain efforts said culture is the biggest thing holding back Wall Street from using the tech

Dan DeFrancesco | Emmanuel Aidoo, Credit Suisse's head of digital asset markets, discusses what will eventually lead to more adoption of the cutting edge tech.

Read More »
Exchanges made nearly $30 billion in 2018, but a new report suggests their business could be at risk if they don't innovate in 3 ways

Exchanges made nearly $30 billion in 2018, but a new report suggests their business could be at risk if they don't innovate in 3 ways

Dan DeFrancesco | Opimas' report suggests exchanges risk the double-digit revenue growth they've enjoyed in recent years if they aren't willing to innovate.

Read More »
Traders are overestimating the lasting impact of corporate tax cuts — and Morgan Stanley says one crucial corner of the market is particularly at-risk

Traders are overestimating the lasting impact of corporate tax cuts — and Morgan Stanley says one crucial corner of the market is particularly at-risk

Marley Jay | Morgan Stanley's chief US equities strategist says capital spending is slowing, creating a threat to tech and other sector that investors are missing.

Read More »
A simple trading strategy made investors 42% in just 6 days last earnings season. Here's how Goldman Sachs says you can replicate it.

A simple trading strategy made investors 42% in just 6 days last earnings season. Here's how Goldman Sachs says you can replicate it.

Joe Ciolli | Goldman Sachs just unveiled a simple earnings-season trading strategy that returned 42% over just six days last quarter.

Read More »
Experts say 'learnability' is the most important skill you'll need to stay relevant at your job. Here's what it is, and how to tell if you have it

Experts say 'learnability' is the most important skill you'll need to stay relevant at your job. Here's what it is, and how to tell if you have it

Shana Lebowitz | When you're looking for a job, it's important to show you're willing to learn and grow by talking about skills you've developed in previous roles.

Read More »
Here's why companies like Google, Square, and Atlassian are sprinting to use Kotlin, the fastest-growing programming language according to GitHub

Here's why companies like Google, Square, and Atlassian are sprinting to use Kotlin, the fastest-growing programming language according to GitHub

Rosalie Chan | Companies like Google, Square, Atlassian, and Capital One are increasingly using Kotlin, the fastest-growing programming language according to GitHub.

Read More »
The JPMorgan, Amazon, and Berkshire Hathaway healthcare venture is setting up shop in NYC to snag top tech workers

The JPMorgan, Amazon, and Berkshire Hathaway healthcare venture is setting up shop in NYC to snag top tech workers

Lydia Ramsey | The new company is opening a New York office near Union Square in Manhattan and plans to hire for technology and engineering roles.

Read More »
A Jeff Bezos-backed startup just inked a deal with $84 billion biotech Gilead to make drugs for a troubling and increasingly common disease

A Jeff Bezos-backed startup just inked a deal with $84 billion biotech Gilead to make drugs for a troubling and increasingly common disease

Erin Brodwin | Insitro and Gilead are teaming up to create drugs for a liver disease affecting millions. The startup is backed by Jeff Bezos and Andreessen Horowitz.

Read More »
Snap's New Guard: Meet the 25 new power players who help CEO Evan Spiegel run Snap Inc.

Snap's New Guard: Meet the 25 new power players who help CEO Evan Spiegel run Snap Inc.

Tanya Dua | A string of executives departed Snap, Snapchat's parent company, in the last two years. Here is the new guard who have taken their place.

Read More »

Share This Email

  

Read Business Insider On The Go

App Store    Google Play



Email sent to: ipat39@gmail.com

Manage your email preferences   |   Unsubscribe

Terms of Service   |   Privacy Policy

Business Insider. 150 Fifth Ave, New York, NY 10011
Powered By SailthrU

Tidak ada komentar:

Posting Komentar